Bivalent CAR-T Cells Via CSF Injection Show Activity in Recurrent Glioblastoma
(MedPage Today) -- CHICAGO -- Intracerebroventricular (ICV) delivery of bivalent CAR T-cells targeting EGFR and IL13RĪ±2 was feasible and appeared safe in patients with recurrent glioblastoma (GBM) in a phase I study that also signaled an...